Bald's eyesalve is an early medieval English medicine recorded in the 10th-century Anglo-Saxon Bald's Leechbook . It is described as a treatment for a "wen", a lump in the eye. The ingredients include garlic, another Allium (it is unclear which), wine and bovine bile, crushed and mixed together before being left to stand for nine days.
Bald's Eyesalve is a medicine described in Bald's Leechbook , a 10th-century Anglo-Saxon medical text written in Old English that survives in the collection of the British Library. [1] : 1 [2] The identity of Bald is not known but he is named in the work by a note that states "Bald owns this book which he ordered Cild to compile". [3] The eyesalve is described as a treatment for a "wen" (lump) in the eye ("most likely a sty: an infection of an eyelash follicle"). [1] : 1 Bald's Leechbook includes other treatments such as agrimony boiled in milk to combat impotency and the same substance boiled in Welsh beer to induce impotency. [3]
The recipe for the eyesalve consists of equal parts of garlic, crushed by mortar and pestle, and "cropleac" (another Allium species, the translation from Old English is ambiguous; modern reproductions have used onion or leek) and equal parts (the text is ambiguous as to whether these ingredients are equal with the Allium components) of wine and oxgall (bovine bile). The mixture is left to stand in a brass or bronze container for nine days before being wrung through a cloth and clarified. The text states that the medicine should be stored in a horn and applied to the infected area with a feather at night time. The leechbook describes the mixture as se betsta læcedom (transl. the best medicine). [1] : 1
Ƿyrc eaȝsealf ƿiþ ƿænne: ȝenim cropleac ⁊ ȝarleac beȝea emfela, ȝecnuƿe ƿel tosomne, ȝenim ƿin ⁊ fearres ȝeallen beȝean emfela ȝemenȝ ƿiþ þy leaces, do þonne on arfæt læt standan niȝon niht on þæm arfæt aƿrinȝ þurh claþ ⁊ hlyttre ƿel, do on horn ⁊ ymb niht do mid feþre on eaȝe; se betsta læcedom | Make an eyesalve against a wen: take equal amounts of cropleac and garlic, pound well together, take equal amounts of wine and oxgall, mix with the alliums, put this in a brass vessel, let [the mixture] stand for nine nights in the brass vessel, wring through a cloth and clarify well, put in a horn and at night apply to the eye with a feather; the best medicine |
| —Old English text in Bald's Leechbook | —Modern English translation by the British Library [1] : 2 |
A study published in 2015 explored the "ancientbiotic" potential of Bald's eyesalve. A "wen" was most likely a stye, which is caused by the Gram-positive bacterium Staphylococcus aureus, and the researchers found that the Bald remedy repeatedly killed established S. aureus biofilms in an in vitro model. The remedy also killed methicillin-resistant S. aureus (MRSA) in a mouse chronic wound model. The researchers conclude that their study indicated the importance of investigating the combined activity of ingredients in historic remedies. [1]
A follow-up study published in 2020 found that the eyesalve had a significant anti-biofilm effect. The remedy of combined ingredients was effective at reducing biofilms of S. epidermidis and MRSA and eradicating biofilms of S. aureus Newman, A. baumannii and S. pyogenes in an established soft-tissue wound model. [4]
In the 2020 study, researchers compared the combined remedy of Bald's eyesalve against individual active ingredients, the latter mirroring current drug development practices of isolating single active compounds from historic rememdies. Whilst garlic could reduce numbers of bacteria, it had no effect upon biofilms, which is a more relevant test of clinical efficacy. Only the presence of all four ingredients resulted in an effective remedy. [4]
The researchers also tested variants of the eyesalve made with onion and with leek, since it was unclear which might have been used in the original recipe. A preparation made with onion was found to be more effective than one made with leek. [4]
The shallot is a cultivar group of the onion. Until 2010, the shallot was classified as a separate species, Allium ascalonicum. The taxon was synonymized with Allium cepa in 2010, as the difference was too small to justify a separate species.
Garlic is a species of bulbous flowering plant in the genus Allium. Its close relatives include the onion, shallot, leek, chive, Welsh onion, and Chinese onion. It is native to South Asia, Central Asia and northeastern Iran and has long been used as a seasoning worldwide, with a history of several thousand years of human consumption and use. It was known to ancient Egyptians and has been used as both a food flavoring and a traditional medicine. China produced 73% of the world's supply of garlic in 2021.
Staphylococcus aureus is a Gram-positive spherically shaped bacterium, a member of the Bacillota, and is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen. Although S. aureus usually acts as a commensal of the human microbiota, it can also become an opportunistic pathogen, being a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. S. aureus is one of the leading pathogens for deaths associated with antimicrobial resistance and the emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), is a worldwide problem in clinical medicine. Despite much research and development, no vaccine for S. aureus has been approved.
Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from other strains of Staphylococcus aureus. MRSA is responsible for several difficult-to-treat infections in humans. It caused more than 100,000 deaths worldwide attributable to antimicrobial resistance in 2019.
The Lacnunga ('Remedies') is a collection of miscellaneous Anglo-Saxon medical texts and prayers, written mainly in Old English and Latin. The title Lacnunga, an Old English word meaning 'remedies', is not in the manuscript: it was given to the collection by its first editor, Oswald Cockayne, in the nineteenth century. It is found, following other medical texts, in London, British Library Harley MS 585, a codex probably compiled in England in the late tenth or early eleventh century. Many of its herbal remedies are also found, in variant form, in Bald's Leechbook, another Anglo-Saxon medical compendium.
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.
Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. It was synthesized in order to create an antibiotic with a broader spectrum. It is often grouped with the second-generation cephalosporins. Cefoxitin requires a prescription and as of 2010 is sold under the brand name Mefoxin by Bioniche Pharma, LLC. The generic version of cefoxitin is known as cefoxitin sodium.
Bald's Leechbook is an Old English medical text in English and old Latin probably compiled in the mid-tenth century, possibly under the influence of Alfred the Great's educational reforms.
Lysostaphin is a Staphylococcus simulans metalloendopeptidase. It can function as a bacteriocin (antimicrobial) against Staphylococcus aureus.
Targanta Therapeutics Corporation was a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company also had operations in Indianapolis, Montreal and Toronto. Targanta completed its initial public offering on October 9, 2007 and traded on the Nasdaq market under the symbol: TARG. Targanta was acquired by The Medicines Company in 2009.
Dalbavancin, sold under the brand names Dalvance in the US and Xydalba in the EU among others, is a second-generation lipoglycopeptide antibiotic medication. It belongs to the same class as vancomycin, the most widely used and one of the treatments available to people infected with methicillin-resistant Staphylococcus aureus (MRSA).
Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.
Anglo-Saxon metrical charms were sets of instructions generally written to magically resolve a situation or disease. Usually, these charms involve some sort of physical action, including making a medical potion, repeating a certain set of words, or writing a specific set of words on an object. These Anglo-Saxon charms tell a great deal about medieval medical theory and practice. Although most medical texts found from the pre-Christian Anglo-Saxon period are translations of Classical texts in Latin, these charms were originally written in Old English.
Ceftaroline fosamil (INN), brand name Teflaro in the US and Zinforo in Europe, is a cephalosporin antibiotic with anti-MRSA activity. Ceftaroline fosamil is a prodrug of ceftaroline. It is active against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria. It retains some activity of later-generation cephalosporins having broad-spectrum activity against Gram-negative bacteria, but its effectiveness is relatively much weaker. It is currently being investigated for community-acquired pneumonia and complicated skin and skin structure infection.
Sophoraflavanone G is a volatile phytoncide, released into the atmosphere, soil and ground water, by members of the Sophora genus. Due to an increase in the rates of antibiotic-resistant bacteria, scientific efforts have focused on finding either naturally-made or genetically modified compounds that can treat and or prevent these harmful and sometimes deadly bacteria. Sophoraflavanone G, due to its use as a phytoncide, has been found to impact the growth of antibiotic-resistant bacteria and enhance the effect of currently used antibiotics.
Enzybiotics are an experimental antibacterial therapy first described by Nelson, Loomis, and Fischetti. The term is derived from a combination of the words “enzyme” and “antibiotics.” Enzymes have been extensively utilized for their antibacterial and antimicrobial properties. Proteolytic enzymes called endolysins have demonstrated particular effectiveness in combating a range of bacteria and are the basis for enzybiotic research. Endolysins are derived from bacteriophages and are highly efficient at lysing bacterial cells. Enzybiotics are being researched largely to address the issue of antibiotic resistance, which has allowed for the proliferation of drug-resistant pathogens posing great risk to animal and human health across the globe.
The leek is a vegetable, a cultivar of Allium ampeloprasum, the broadleaf wild leek. The edible part of the plant is a bundle of leaf sheaths that is sometimes erroneously called a stem or stalk. The genus Allium also contains the onion, garlic, shallot, scallion, chives, and Chinese onion. Three closely related vegetables, elephant garlic, kurrat and Persian leek or tareh, are also cultivars of A. ampeloprasum, although different in their uses as food.
Cassandra Leah Quave is an American ethnobotanist, herbarium curator, and associate professor at Emory University. Her research focuses on analyzing natural, plant-based medicine of indigenous cultures to help combat infectious disease and antibiotic resistance. In particular, she studies bacterial biofilm inhibition and quorum-sensing inhibition of botanical extracts for inflammatory skin conditions.
Kerry L. LaPlante is an American pharmacist, academic and researcher. She is a Professor of Pharmacy and the Chair of the Department of Pharmacy Practice at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, an Infectious Diseases Pharmacotherapy Specialist, and the Director of the Rhode Island Infectious Diseases Fellowship and Research Programs at the Veterans Affairs Medical Center in Providence, Rhode Island.
This article incorporates textby The British Library Board available under the CC BY 4.0 license.